US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
JPS63503086A
(ja)
|
1986-03-13 |
1988-11-10 |
バイオテクノロジ− オ−ストラリア プロプライエタリ− リミテッド |
インヒビンの分析法
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US4801575A
(en)
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US4904768A
(en)
|
1987-08-04 |
1990-02-27 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside 4'-phosphate derivatives
|
GB2208511A
(en)
|
1987-08-07 |
1989-04-05 |
Bayer Ag |
Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
|
US4942184A
(en)
|
1988-03-07 |
1990-07-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water soluble, antineoplastic derivatives of taxol
|
US5632990A
(en)
|
1988-04-22 |
1997-05-27 |
Cancer Research Campaign Tech. Ltd. |
Treatment for tumors comprising conjugated antibody A5B7 and a prodrug
|
US5258499A
(en)
|
1988-05-16 |
1993-11-02 |
Vestar, Inc. |
Liposome targeting using receptor specific ligands
|
US5028697A
(en)
|
1988-08-08 |
1991-07-02 |
Eli Lilly And Company |
Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5948634A
(en)
|
1988-12-21 |
1999-09-07 |
The General Hospital Coporation |
Neural thread protein gene expression and detection of alzheimer's disease
|
DE3912638A1
(de)
|
1989-04-18 |
1990-10-31 |
Bayer Ag |
Gentechnologisch hergestellte homologe des alzheimer protease inhibitors, wirtstaemme sowie expressionsvektoren fuer ihre herstellung und ihre verwendung als arzneimittel
|
US5126249A
(en)
|
1989-05-09 |
1992-06-30 |
Eli Lilly And Company |
Enzymatic removal of a protein amino-terminal sequence
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
US6475781B1
(en)
|
1990-05-17 |
2002-11-05 |
Dana-Farber Cancer Institute, Inc. |
Trans-dominant suppressor genes for oligomeric proteins
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
GB9017008D0
(en)
|
1990-08-02 |
1990-09-19 |
Erba Carlo Spa |
Process for the enzymatic preparation of basic fibroblast growth factor
|
JPH07108232B2
(ja)
*
|
1990-10-09 |
1995-11-22 |
エム・ディ・リサーチ株式会社 |
ペプチド又は蛋白質の製造方法
|
US6495513B1
(en)
|
1991-03-11 |
2002-12-17 |
Curis, Inc. |
Morphogen-enhanced survival and repair of neural cells
|
US5955444A
(en)
|
1991-08-09 |
1999-09-21 |
Massachusetts Institute Of Technology |
Method of inhibiting abnormal tau hyper phosphorylation in a cell
|
US5627270A
(en)
|
1991-12-13 |
1997-05-06 |
Trustees Of Princeton University |
Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
|
US5204354A
(en)
|
1992-02-14 |
1993-04-20 |
Merck & Co., Inc. |
Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
|
GB9213077D0
(en)
|
1992-06-19 |
1992-08-05 |
Erba Carlo Spa |
Polymerbound taxol derivatives
|
EP0671944A4
(de)
|
1992-09-25 |
1996-07-24 |
Corvas Int Inc |
Inhibitoren des faktor viia-gewebsfaktorrkomplex abegeleitet vom pankreatischerinder-trypsininhibitor.
|
EP0599303A3
(de)
|
1992-11-27 |
1998-07-29 |
Takeda Chemical Industries, Ltd. |
Peptide-Konjugate
|
WO1994019692A1
(en)
|
1993-02-18 |
1994-09-01 |
The General Hospital Corporation |
Alzheimer's disease therapeutics
|
WO1996031531A2
(en)
|
1995-04-04 |
1996-10-10 |
Advanced Bioconcept, Inc. |
Fluorescent peptides
|
CA2220497A1
(en)
|
1995-05-08 |
1996-11-14 |
Scios, Inc. |
Kunitz type protease inhibitors
|
ZA963619B
(en)
|
1995-05-08 |
1996-11-22 |
Scios Inc |
Protease inhibitor peptides
|
WO1996039183A1
(en)
|
1995-05-31 |
1996-12-12 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for targeted delivery of effector molecules
|
US5780265A
(en)
|
1995-06-05 |
1998-07-14 |
Genentech, Inc. |
Kunitz type plasma kallikrein inhibitors
|
US5665702A
(en)
|
1995-06-06 |
1997-09-09 |
Biomeasure Incorporated |
Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
|
WO1996040210A1
(en)
|
1995-06-07 |
1996-12-19 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth of tumors
|
KR100356956B1
(ko)
|
1996-03-11 |
2003-03-15 |
베이어 코오포레이숀 |
사람비쿠닌
|
WO1997040160A1
(en)
|
1996-04-24 |
1997-10-30 |
Rijksuniversiteit Te Groningen |
A prokaryotic protein having functional and structural homology with the human p-glycoprotein encoded by the mdr-1 gene, nucleic acids encoding and cells expressing said protein
|
CA2252706A1
(en)
|
1996-05-01 |
1997-11-06 |
Antivirals Inc. |
Polypeptide conjugates for transporting substances across cell membranes
|
DE19636889A1
(de)
|
1996-09-11 |
1998-03-12 |
Felix Dr Kratz |
Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
EP0932390A1
(de)
|
1996-10-11 |
1999-08-04 |
Sequus Pharmaceuticals, Inc. |
Therapeutische liposomenzusammensetzung und verfahren
|
US5948750A
(en)
|
1996-10-30 |
1999-09-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
DE69838544T2
(de)
|
1997-03-04 |
2008-07-24 |
Savient Pharmaceuticals, Inc. |
Isolierung von gewebespezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane
|
US6126965A
(en)
|
1997-03-21 |
2000-10-03 |
Georgetown University School Of Medicine |
Liposomes containing oligonucleotides
|
GB9705903D0
(en)
|
1997-03-21 |
1997-05-07 |
Elliott Gillian D |
VP22 Proteins and uses thereof
|
US6306993B1
(en)
|
1997-05-21 |
2001-10-23 |
The Board Of Trustees Of The Leland Stanford, Jr. University |
Method and composition for enhancing transport across biological membranes
|
US6391305B1
(en)
|
1997-09-10 |
2002-05-21 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US6093692A
(en)
|
1997-09-25 |
2000-07-25 |
The University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
US6475481B2
(en)
|
1997-11-18 |
2002-11-05 |
Canji Inc |
Purging of stem cell products
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
WO1999046575A2
(en)
|
1998-03-12 |
1999-09-16 |
Georgetown University Medical Center |
Peptides containing a cholesterol recognition sequence and their uses
|
US5981564A
(en)
|
1998-07-01 |
1999-11-09 |
Universite Laval |
Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
|
GB9814527D0
(en)
|
1998-07-03 |
1998-09-02 |
Cyclacel Ltd |
Delivery system
|
US6703381B1
(en)
|
1998-08-14 |
2004-03-09 |
Nobex Corporation |
Methods for delivery therapeutic compounds across the blood-brain barrier
|
US5922754A
(en)
|
1998-10-02 |
1999-07-13 |
Abbott Laboratories |
Pharmaceutical compositions containing paclitaxel
|
WO2000050059A1
(en)
|
1999-02-24 |
2000-08-31 |
The Uab Research Foundation |
Taxane derivatives for targeted therapy of cancer
|
US6138375A
(en)
*
|
1999-03-01 |
2000-10-31 |
Gala Industries, Inc. |
Support ring for pellet dryer screen
|
US6713454B1
(en)
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
ES2288871T3
(es)
|
1999-09-24 |
2008-02-01 |
Genentech, Inc. |
Derivados de tirosina.
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
DE19953696A1
(de)
*
|
1999-11-09 |
2001-05-10 |
Alexander Cherkasky |
Selektive proteolytische Synzyme (SPS)
|
DE19953966A1
(de)
*
|
1999-11-09 |
2001-05-10 |
Leica Microsystems |
Verfahren und Vorrichtung zur Dickenmessung an transparenten Schichten
|
GB2360453B
(en)
|
2000-01-05 |
2004-09-01 |
Univ Cardiff |
Treatment of skin conditions
|
US20020086384A1
(en)
|
2000-03-14 |
2002-07-04 |
Zurit Levine |
Splice variants of oncogenes
|
CA2355334A1
(en)
|
2000-10-16 |
2002-04-16 |
Procyon Biopharma Inc. |
Pharmaceutical preparations and methods for inhibiting tumors
|
ES2284711T3
(es)
|
2000-10-20 |
2007-11-16 |
Abbott Laboratories |
Tiagabina para el tratamiento de neuropatia diabetica.
|
JP2004536026A
(ja)
|
2000-11-28 |
2004-12-02 |
トランスフォーム ファーマシューティカルズ,インコーポレーティッド. |
パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
|
IL157993A0
(en)
|
2001-03-23 |
2004-03-28 |
Napro Biotherapeutics Inc |
Molecular conjugates for use in cancer treatment and methods for the preparation thereof
|
CA2443757C
(en)
|
2001-04-19 |
2016-09-27 |
The Scripps Research Institute |
In vivo incorporation of unnatural amino acids
|
AU2002322720B2
(en)
|
2001-07-25 |
2008-11-13 |
Raptor Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
US20040161776A1
(en)
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
US7192921B2
(en)
|
2001-11-08 |
2007-03-20 |
The Burnham Institute |
Peptides that home to tumor lymphatic vasculature and methods of using same
|
DE60314495T2
(de)
|
2002-02-07 |
2008-03-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Aminosäuresequenzen, die in der lage sind die durchdringung einer biologischen barriere zu erleichtern
|
DE60329089D1
(de)
|
2002-03-29 |
2009-10-15 |
Creagene Inc |
Zytoplasmatische transduktionspeptide und deren verwendungen
|
US6881829B2
(en)
|
2002-04-26 |
2005-04-19 |
Chimeracom, L.L.C. |
Chimeric hybrid analgesics
|
CA2487815A1
(en)
|
2002-05-29 |
2003-12-11 |
Symbiontics, Inc. |
Targeted therapeutic proteins
|
US20040077540A1
(en)
|
2002-06-28 |
2004-04-22 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
|
US7829694B2
(en)
|
2002-11-26 |
2010-11-09 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
US20040102369A1
(en)
|
2002-11-27 |
2004-05-27 |
The Regents Of The University Of California |
Transport of basic fibroblast growth factor across the blood brain barrier
|
US7319090B2
(en)
|
2002-11-27 |
2008-01-15 |
University Of North Carolina At Chapel Hill |
Methods of treating cerebral ischemia
|
EP1583562B1
(de)
|
2003-01-06 |
2011-06-15 |
Angiochem Inc. |
Angiopep-1, verwandte verbindungen, und deren verwnedungen
|
US20040162284A1
(en)
|
2003-02-19 |
2004-08-19 |
Harris Herbert W. |
Method of lowering body temperature with (S) tofisopam
|
WO2005046569A2
(en)
|
2003-04-08 |
2005-05-26 |
Biotempt B.V. |
Pharmaceutical compositions for the treatment of sars
|
DE60336978D1
(de)
|
2003-04-11 |
2011-06-16 |
Pasteur Institut |
Synthetische Peptid-HIV-Vakzine: das CBD-Epitop als effizientes Immunogen zur Induktion HIV-neutralisierender Antikörper
|
AU2003286870A1
(en)
|
2003-06-05 |
2005-01-04 |
Salk Institute For Biological Studies |
Targeting polypeptides to the central nervous system
|
US20050026823A1
(en)
|
2003-06-20 |
2005-02-03 |
Biomarin Pharmaceutical Inc. |
Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
|
JP5624256B2
(ja)
|
2003-06-20 |
2014-11-12 |
ラプター・ファーマシューティカル・インコーポレイテッド |
脳および他の組織への治療化合物の送達
|
KR20060036476A
(ko)
|
2003-08-08 |
2006-04-28 |
가부시키가이샤 티슈 타겟팅 쟈판 |
뇌 이동 활성을 가지는 폴리펩티드 및 그 이용
|
WO2005021579A2
(en)
|
2003-08-28 |
2005-03-10 |
Biorexis Pharmaceutical Corporation |
Epo mimetic peptides and fusion proteins
|
US20050058702A1
(en)
|
2003-09-17 |
2005-03-17 |
Ben-Sasson Shmuel A. |
Compositions capable of facilitating penetration across a biological barrier
|
US20050208095A1
(en)
|
2003-11-20 |
2005-09-22 |
Angiotech International Ag |
Polymer compositions and methods for their use
|
US7208174B2
(en)
|
2003-12-18 |
2007-04-24 |
Hoffmann-La Roche Inc. |
Liposome compositions
|
CA2569381A1
(en)
|
2004-07-21 |
2006-08-31 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
EP1799826B1
(de)
|
2004-09-29 |
2009-08-12 |
Children's Memorial Hospital |
siRNA-VERMITTELTES GEN-SILENCING VON ALPHA-SYNUKLEIN
|
US9002652B1
(en)
|
2005-01-27 |
2015-04-07 |
Institute For Systems Biology |
Methods for identifying and using organ-specific proteins in blood
|
US20090016959A1
(en)
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
MX2007009960A
(es)
|
2005-02-18 |
2008-03-11 |
Abraxis Bioscience Inc |
Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion.
|
PT2360258E
(pt)
|
2005-02-18 |
2015-01-13 |
Angiochem Inc |
Moléculas para transportar um composto através da barreira hematoencefálica
|
PL1877099T3
(pl)
|
2005-04-06 |
2013-02-28 |
Genzyme Corp |
Terapeutyczne koniugaty zawierające enzym lizosomalny, kwas polisialowy i grupę kierującą
|
AU2006247471A1
(en)
|
2005-05-12 |
2006-11-23 |
Tapestry Pharmaceuticals, Inc. |
Molecular constructs suitable for targeted conjugates
|
WO2006138343A2
(en)
|
2005-06-14 |
2006-12-28 |
Raptor Pharmaceutical Inc. |
Compositions comprising receptor - associated protein (rap) variants specific for lrp2 and uses thereof
|
PL2233156T3
(pl)
|
2005-07-15 |
2013-09-30 |
Angiochem Inc |
Zastosowanie polipeptydów aprotyninowych jako nośników w koniugatach farmaceutycznych
|
MX2008000994A
(es)
|
2005-07-19 |
2008-03-19 |
Univ Illinois |
Agentes de transporte para cruzar la barrera hematoencefalica y hacia el interior de las celulas de cancer cerebral, y metodos para el uso de los mismos.
|
GB0517092D0
(en)
|
2005-08-19 |
2005-09-28 |
Novartis Ag |
New compositions containing taxane derivatives
|
JP2009507852A
(ja)
|
2005-09-08 |
2009-02-26 |
エムディーアールエヌエー,インコーポレイテッド |
リボ核酸の細胞への送達用医薬組成物
|
US9062126B2
(en)
|
2005-09-16 |
2015-06-23 |
Raptor Pharmaceuticals Inc. |
Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
|
EP1996220B2
(de)
|
2006-03-06 |
2023-08-16 |
Amunix Operating Inc. |
Unstrukturierte rekombinante polymere und verwendungen davon
|
US8053569B2
(en)
|
2005-10-07 |
2011-11-08 |
Armagen Technologies, Inc. |
Nucleic acids encoding and methods of producing fusion proteins
|
CA2627585A1
(en)
|
2005-11-01 |
2007-05-10 |
Alnylam Pharmaceuticals, Inc. |
Rnai inhibition of influenza virus replication
|
US8039432B2
(en)
|
2005-11-09 |
2011-10-18 |
Conjuchem, Llc |
Method of treatment of diabetes and/or obesity with reduced nausea side effect
|
US8290433B2
(en)
|
2007-11-14 |
2012-10-16 |
Blaze Mobile, Inc. |
Method and system for securing transactions made through a mobile communication device
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
US7477504B1
(en)
|
2006-03-13 |
2009-01-13 |
C.P.D. Technologies, Inc. |
Versatile stun glove
|
PT1996621E
(pt)
|
2006-03-30 |
2010-03-08 |
Glaxo Group Ltd |
Anticorpos contra o péptido beta-amilóide
|
CA2657649A1
(en)
|
2006-07-13 |
2008-08-21 |
Burnham Institute For Medical Research |
Methods and compositions for targeting gc1qr/p32
|
EP2046826B1
(de)
|
2006-07-24 |
2011-09-14 |
Biorexis Pharmaceutical Corporation |
Exendin-fusionsproteine
|
WO2008036682A2
(en)
|
2006-09-18 |
2008-03-27 |
Raptor Pharmaceutical Inc. |
Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
|
WO2008046228A1
(en)
|
2006-10-19 |
2008-04-24 |
Angiochem, Inc. |
Compounds for stimulating p-glycoprotein function and uses thereof
|
US9399675B2
(en)
|
2007-02-28 |
2016-07-26 |
The Board Of Regents Of The University Of Oklahoma |
Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
|
KR20100015786A
(ko)
|
2007-03-21 |
2010-02-12 |
랩터 파마슈티컬 인코포레이티드 |
환형의 수용체-연관된 단백질(rap) 펩티드
|
EP2164866B1
(de)
|
2007-05-29 |
2014-05-14 |
Angiochem Inc. |
Aprotininähnliche polypeptide zum transport von damit konjugierten mitteln in gewebe
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
WO2009039188A1
(en)
|
2007-09-17 |
2009-03-26 |
Ludwig Institute For Cancer Research Ltd |
Peptides and methods for the treatment of gliomas and other cancers
|
CN101939027B
(zh)
|
2007-10-02 |
2014-07-30 |
玛瑞纳生物技术有限公司 |
用于递送核酸的脂肽
|
WO2009070597A2
(en)
|
2007-11-26 |
2009-06-04 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of gdnf to the cns
|
EP2235175A4
(de)
|
2007-12-20 |
2012-04-25 |
Angiochem Inc |
Polypeptid-nukleinsäure-konjugate und verwendungen davon
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
US11260133B2
(en)
|
2008-02-21 |
2022-03-01 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to peptides and proteins with C-terminal elements
|
US8710013B2
(en)
|
2008-04-18 |
2014-04-29 |
Angiochem Inc. |
Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
|
US20110117627A1
(en)
|
2008-07-10 |
2011-05-19 |
The Board Of Trustees Of The University Of Illinois |
Regulation of apoptosis by neural specific splice variants of ig20
|
US8921314B2
(en)
|
2008-10-15 |
2014-12-30 |
Angiochem, Inc. |
Conjugates of GLP-1 agonists and uses thereof
|
WO2010043049A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Etoposide and doxorubicin conjugates for drug delivery
|
EP2370471B1
(de)
|
2008-12-05 |
2017-02-22 |
Angiochem Inc. |
Neurotensin konjugat und seine verwendungen
|
MX2011005965A
(es)
|
2008-12-05 |
2011-09-01 |
Angiochem Inc |
Conjugados de leptina y de análogos de leptina y sus usos de los mismos.
|
WO2010063124A1
(en)
|
2008-12-05 |
2010-06-10 |
Angiochem Inc. |
Peptide therapeutic conjugates and uses thereof
|
AU2009327267A1
(en)
|
2008-12-17 |
2011-07-14 |
Angiochem, Inc. |
Membrane type-1 matrix metalloprotein inhibitors and uses thereof
|
US9173891B2
(en)
|
2009-04-20 |
2015-11-03 |
Angiochem, Inc. |
Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
|
US20100284921A1
(en)
|
2009-05-08 |
2010-11-11 |
Temple University - Of The Commonwealth System Of Higher Education |
Targeted nanoparticles for intracellular cancer therapy
|
JP2012528882A
(ja)
|
2009-06-03 |
2012-11-15 |
ダイセルナ ファーマシューティカルズ, インコーポレイテッド |
ペプチドダイサー基質剤およびその特異的な遺伝子発現阻害のための方法
|
JP2012529272A
(ja)
|
2009-06-11 |
2012-11-22 |
アンジオケム インコーポレーテッド |
Gdnfおよびbdnfを中枢神経系へ送達するための融合タンパク質
|
IN2012DN00248A
(de)
|
2009-07-02 |
2015-05-01 |
Angiochem Inc |
|
ES2562463T3
(es)
|
2009-07-14 |
2016-03-04 |
Mayo Foundation For Medical Education And Research |
Administración no covalente, mediada por péptidos, de agentes activos a través de la barrera hematoencefálica
|
WO2011041897A1
(en)
|
2009-10-06 |
2011-04-14 |
Angiochem Inc. |
Compositions and methods for the transport of therapeutic agents
|
US8530429B2
(en)
|
2009-11-24 |
2013-09-10 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
US9095541B2
(en)
|
2009-11-24 |
2015-08-04 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
EP2333074A1
(de)
|
2009-12-14 |
2011-06-15 |
Robert Steinfeld |
Substanzen und Verfahren zur Behandlung von lyosomalen Speicherkrankheiten
|
US9180105B2
(en)
|
2010-03-08 |
2015-11-10 |
Sloan-Kettering Institute For Cancer Research |
CDC7 kinase inhibitors and uses thereof
|
WO2011119549A1
(en)
|
2010-03-22 |
2011-09-29 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011119608A1
(en)
|
2010-03-26 |
2011-09-29 |
University Of Tennessee Research Foundation |
Peptides that specifically target amyloid deposits
|
EP2558503B1
(de)
|
2010-04-14 |
2015-12-09 |
National Research Council of Canada |
Zusammensetzungen und verfahren zur freisetzung schmerzstillender peptide im hirn
|
WO2011153642A1
(en)
|
2010-06-10 |
2011-12-15 |
Angiochem Inc. |
Leptin and leptin analog conjugates and fusion proteins and uses thereof
|
JP2013530993A
(ja)
|
2010-07-02 |
2013-08-01 |
アンジオケム インコーポレーテッド |
治療用コンジュゲートのための短く且つd−アミノ酸を含有するポリペプチドおよびその使用
|
US8218280B2
(en)
|
2010-07-08 |
2012-07-10 |
Schneider Electric USA, Inc. |
Secondary thermal sensor for primary conductors
|
CA2815154A1
(en)
|
2010-08-06 |
2012-02-09 |
U3 Pharma Gmbh |
Use of her3 binding agents in prostate treatment
|
CN102406949B
(zh)
|
2010-09-21 |
2013-05-29 |
复旦大学 |
一种靶向示踪的多模式诊断纳米影像药物
|
WO2012037687A1
(en)
|
2010-09-23 |
2012-03-29 |
Angiochem Inc. |
Therapeutic polypeptides and uses thereof
|
EP2637669A4
(de)
|
2010-11-10 |
2014-04-02 |
Infinity Pharmaceuticals Inc |
Heterocyclische verbindungen und ihre verwendung
|
RU2013127625A
(ru)
|
2010-11-18 |
2014-12-27 |
Зе Дженерал Хоспитал Корпорейшен |
Новые композиции и применения антигипертензивных средств для терапии рака
|
CN102552928A
(zh)
|
2010-12-19 |
2012-07-11 |
复旦大学 |
一种治疗脑部肿瘤的双级靶向递药***及其制备方法
|
CN103648499B
(zh)
|
2011-01-10 |
2017-02-15 |
无限药品股份有限公司 |
用于制备异喹啉酮的方法及异喹啉酮的固体形式
|
CN102614105A
(zh)
|
2011-01-28 |
2012-08-01 |
复旦大学 |
一种脑靶向载两性霉素b聚合物胶束给药***
|
JP2014506922A
(ja)
|
2011-03-01 |
2014-03-20 |
ティーオー − ビービービー ホールディング ベスローテン フェンノートシャップ |
難水溶性物質の高度なアクティブリポソームローディング
|
US9238716B2
(en)
|
2011-03-28 |
2016-01-19 |
Massachusetts Institute Of Technology |
Conjugated lipomers and uses thereof
|
EP2952210A3
(de)
|
2011-04-07 |
2016-03-16 |
Emory University |
Zusammensetzungen mit saccharidbindenden teilen und verfahren zur gezielten therapie
|
US20140213641A1
(en)
|
2011-05-09 |
2014-07-31 |
Institut Quimic De Sarria |
Polymeric nanoparticles for drug delivery
|
WO2013004716A1
(en)
|
2011-07-04 |
2013-01-10 |
Universität Basel |
Peptide beads
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
AU2012284091B2
(en)
|
2011-07-19 |
2015-11-12 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
RU2636588C2
(ru)
|
2011-08-11 |
2017-11-24 |
ИНТЕЛЛАЙКИН, ЭлЭлСи |
Полиморфы ингибитора киназы
|
CN103998442B
(zh)
|
2011-08-29 |
2016-09-14 |
无限药品股份有限公司 |
杂环化合物及其用途
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
WO2013056096A1
(en)
|
2011-10-13 |
2013-04-18 |
Angiochem Inc. |
Polypeptide-opioid conjugates and uses thereof
|
PE20181541A1
(es)
|
2011-10-27 |
2018-09-26 |
Massachusetts Inst Technology |
Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco
|
EP2776428A4
(de)
|
2011-11-11 |
2015-04-22 |
Intellikine Llc |
Kinasehemmerpolymorphe
|
CN104136606A
(zh)
|
2011-12-01 |
2014-11-05 |
安吉奥开米公司 |
靶向的艾杜糖-2-硫酸酯酶化合物
|
BR112014013161A2
(pt)
|
2011-12-01 |
2019-09-24 |
Angiochem Inc |
compostos com enzima lisossomal alvo
|
RU2664698C2
(ru)
|
2011-12-13 |
2018-08-21 |
Энджинеик Молекьюлар Деливери Пти Лтд |
Полученные из бактерий интактные мини-клетки для доставки лекарственных средств к опухолям мозга
|
EP2791210A1
(de)
|
2011-12-16 |
2014-10-22 |
Massachusetts Institute of Technology |
Alpha-aminoamidinpolymere und ihre verwendung
|
WO2013120107A1
(en)
|
2012-02-09 |
2013-08-15 |
University Of Rochester |
Methods and compositions for treating a subject to inhibit hearing loss
|
WO2013131032A1
(en)
|
2012-03-02 |
2013-09-06 |
Icahn School Of Medicine At Mount Sinai |
Variants of prothymosin alpha and methods of using same
|
ES2673093T3
(es)
|
2012-04-04 |
2018-06-19 |
Halozyme, Inc. |
Terapia combinada con hialuronidasa y un taxano dirigido a un tumor
|
EP4005600A1
(de)
|
2012-04-26 |
2022-06-01 |
Yale University |
Gegen hiv gerichtete zytotoxische wirkstoffe freisetzende moleküle (cdm-hs), zytotoxische wirkung gegen das menschliche immunschwächevirus und verfahren zur verwendung
|
AU2013273894A1
(en)
|
2012-06-15 |
2015-02-05 |
Angiochem Inc. |
Targeted iduronidase compounds
|